Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up

British Journal of Surgery

Volumn 99, Issue 4, 2012, Pages 515-522

  Barczynski M ^a   Konturek, A ^a   Hubalewska Dydejczyk, A ^a   Golkowski F ^a   Nowak, W ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; MALE; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; THYROIDECTOMY; VOCAL CORD PARALYSIS;

DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; HYPOCALCEMIA; HYPOPARATHYROIDISM; MALE; MIDDLE AGED; RECURRENCE; THYROIDECTOMY; VOCAL CORD PARALYSIS;

EID: 84858079340     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8660     Document Type: Article

References (24)

1. In H, Pearce EN, Wong AK, Burgess JF, McAneny DB, Rosen JE,. Treatment options for Graves disease: a cost-effectiveness analysis. J Am Coll Surg 2009; 209: 170-179.
2. Stiebel-Kalish H, Robenshtok E, Hasanreisoglu M, Ezrachi D, Shimon I, Leibovici L,. Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. J Clin Endocrinol Metab 2009; 94: 2708-2716.
3. Stalberg P, Svensson A, Hessman O, Akerström G, Hellman P,. Surgical treatment of Graves' disease: evidence-based approach. World J Surg 2008; 32: 1269-1277.
4. Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH,. Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease? Thyroid 2005; 15: 569-574. (Pubitemid 40993730)
5. Feliciano DV, Lyons JD,. Thyroidectomy is optimal treatment for Graves' disease. J Am Coll Surg 2011; 212: 714-720.
6. Liu J, Bargren A, Schaefer S, Chen H, Sippel RS,. Total thyroidectomy: a safe and effective treatment for Graves' disease. J Surg Res 2011; 168: 1-4.
7. Järhult J, Rudberg C, Larsson E, Selvander H, Sjövall K, Winsa B, et al.,; TEO Study Group. Graves disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection. Thyroid 2005; 15: 1157-1164. (Pubitemid 41720722)
8. Barczyński M, Konturek A, Hubalewska-Dydejczyk A, Gołkowski F, Cichoń S, Nowak W,. Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter. World J Surg 2010; 34: 1203-1213.
9. Barczyński M, Konturek A, Stopa M, Cichoń S, Richter P, Nowak W,. Total thyroidectomy for benign thyroid disease-is it really worthwhile? Ann Surg 2011; 254: 724-730.
10. Barczyński M, Konturek A, Cichoń S,. Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg 2009; 96: 240-246.
11. Palit TK, Miller CC, Miltenburg DM,. The efficacy of thyroidectomy for Graves' disease: a meta-analysis. J Surg Res 2000; 90: 161-165. (Pubitemid 30314455)
12. Wilhelm SM, McHenry CR,. Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves disease in the United States. World J Surg 2010; 34: 1261-1264.
13. European Group on Graves Orbitopathy (EUGOGO), Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, et al., Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 2006; 155: 387-389. (Pubitemid 44463943)
14. Bartalena L, Baldeschi L, Dickson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al.,; European Group on Graves' Orbitopathy (EUGOGO). Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008; 158: 273-285. (Pubitemid 351404990)
15. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L,. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1997; 47: 9-14. (Pubitemid 27313981)
16. Wells SA Jr, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM,. Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 1975; 78: 34-44.
17. Winsa B, Rastad J, Akerström G, Johansson H, Westermark K, Karlsson FA,. Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. Eur J Endocrinol 1995; 132: 406-412.
18. Bartalena L,. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. J Clin Endocrinol Metab 2011; 96: 592-599.
19. Witte J, Goretzki P, Dotzenrath C, Simon D, Felis P, Neubauer M, et al., Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg 2000; 24: 1303-1311.
20. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al.,; American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011; 17: 456-520.
21. Bron LP, O'Brien CJ,. Total thyroidectomy for clinically benign disease of the thyroid gland. Br J Surg 2004; 91: 569-574. (Pubitemid 38624664)
22. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, et al., Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med 1992; 326: 1733-1738.
23. Menconi F, Marinò M, Pinchera A, Rocchi R, Mazzi B, Nardi M, et al., Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab 2007; 92: 1653-1658. (Pubitemid 46997167)
24. Eckstein AK, Plicht M, Lax H, Neuhäuser M, Mann K, Lederbogen S, et al., Thyrotropin receptor autoantibodies are independent risk factor for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006; 91: 3464-3470. (Pubitemid 44402120)